China Medical Device Registration Renewal: Deadlines, Deemed Approval and Fees

1. Key takeaways

Renewal looks like a routine continuation and is under-estimated. The risks sit in two places: the renewal windows of the two certificates are not synchronised, and five years of unrecorded changes surface at once during dossier assembly.

• The registration certificate is valid for 5 years. Article 22, paragraph 1 of the Regulations sets this term for Class II and Class III.
• The renewal application is due at least 6 months before expiry.
• Where no decision is made in time, renewal is deemed granted. Article 22, paragraph 2 establishes implied approval for Class III devices: expiry without a decision leads to renewal, not lapse.
• Class III devices have statutory grounds for refusal of renewal (Article 22, paragraph 3). Where these exist, implied approval does not apply.
• The renewal fee is CNY 40,800, uniform across domestic Class III, imported Class II and imported Class III (article 35).
• The production licence window differs: between 90 working days and 30 working days before expiry (Production Measures, Article 17), a range, not a single date.
• The renewal dossier centres on post-market evidence: five years of changes, adverse events and recalls, and surveillance results.

In our assessment, changes over five years, without a ledger, surface in a burst at dossier assembly. GRZAN recommends building the renewal dossier file from the day of issuance, not one year before expiry.

2. Legal basis

Medical Device Supervision and Administration Regulations (State Council Order No. 739, promulgated 9 February 2021, effective 1 June 2021)

• Article 22, paragraph 1: the certificate is valid for 5 years; renewal is applied for to the original registering authority at least 6 months before expiry.
• Article 22, paragraph 2: the department shall decide before expiry; where no decision is made in time, renewal is deemed granted.
• Article 22, paragraph 3: the circumstances in which Class III devices are not renewed.
• Article 39: instructions and labels shall be consistent with the registered or filed content.

Medical Device Registration and Filing Measures (SAMR Order No. 47, promulgated 26 August 2021, effective 1 October 2021)

• Article 5: the Center for Medical Device Evaluation of the NMPA reviews domestic Class III, imported Class II and III registration, variation and renewal applications.
• Article 79: substantive changes require variation; other changes are filed within 30 days; holder and agent names and domiciles are filing items.
• Article 19: products shall comply with applicable mandatory standards; non-applicable items need an explanation.
• Article 107: failure to file brings an order to correct and, on expiry, a fine of CNY 10,000 to CNY 30,000.
• Article 117: electronic certificates have the same legal effect as paper documents.

Measures for the Supervision and Administration of Medical Device Production (SAMR Order No. 53, promulgated 10 March 2022, effective 1 May 2022)

• Article 14: the production licence is valid for 5 years; electronic certificates equal paper ones.
• Article 17: renewal is applied for between 90 working days and 30 working days before expiry.

Provisions on the Administration of Medical Device Instructions and Labels (former CFDA Order No. 6, promulgated 30 July 2014, effective 1 October 2014), Article 4: content consistent with the registered or filed content. Announcement No. 121 of 2021 (effective 1 January 2022) sets the renewal dossier format. Article 15 of the Unique Device Identification System Rules (NMPA, 2019): identifiers and related data uploaded before marketing.

Practical estimate. The latest submission point is normally no later than 6 months before expiry; preparation is recommended to start 12 months before expiry (practical estimate).

3. Expert insights

Insight 1: a 5-year term and a 6-month window compress preparation to 4 years and 6 months.

Five years look generous, but subtracting the 6-month advance submission leaves 4 years and 6 months. Multiple changes over the term make assembly substantial. Starting 12 months before expiry buys room for correction.

Insight 2: deemed approval is implied approval, and its application has boundaries.

Paragraph 2 provides that where no decision is made in time, renewal is deemed granted, removing supply interruption risk from administrative delay: an on-time applicant does not fall into a certificate vacuum. The boundary is the opening words, except for the circumstances prescribed in paragraph 3. Implied approval is a procedural presumption, not proof of substantive review; where a paragraph 3 circumstance exists, deemed grant does not apply.

The last row carries the heaviest consequence: a late application loses implied approval coverage.

Insight 3: two certificates, two renewal windows, one parallel schedule.

The windows differ: no later than a point, versus acceptance within a range — earlier than 90 working days not accepted, later than 30 working days missed. Converting 90 working days to about 4.5 calendar months and 30 working days to 1.5 calendar months (practical estimate), the licence range falls between roughly 4.5 and 1.5 months before expiry, not coinciding with the 6-month point; holders of both certificates need separate reminders.

Insight 4: the renewal dossier centres on post-market evidence. Following the dossier logic of Announcement No. 121 of 2021:

Item 1 is where problems concentrate: without a unified ledger, assembly reveals certificate particulars no longer match the actual product, forcing supplementary filings that collide with the renewal window. Item 4 is often overlooked: standards may be revised during the term and applicability re-checked with explanations.

4. Practical recommendations

• Build the renewal dossier file from the date of issuance, archiving changes, filings, adverse events and recalls, and instruction versions by year.
• Set an internal start reminder at 12 months before expiry (practical estimate), working back from the latest submission point.
• Keep separate ledgers: the registration certificate against the at-least-6-months point, the licence against the 90 to 30 working day range, alerts at both endpoints.
• Check current mandatory standard versions, submitting explanations for non-applicable items (Article 19).
• Run a consistency self-check before submitting: certificate particulars, filings, technical requirements, instructions and labels, UDI data.
• Verify agent information in parallel: unfiled name or domicile changes bring a fine of CNY 10,000 to CNY 30,000 on expiry (Article 107).

5. Verification checklist

• □ Certificate term confirmed: 5 years from issuance (Article 22, paragraph 1).
• □ Renewal scheduled: no later than 6 months before expiry.
• □ Internal preparation start set: 12 months before expiry (practical estimate).
• □ Variation and filing records compiled into a ledger, consistent with current product status.
• □ Holder and agent filings checked, no overdue unfiled changes (Article 79).
• □ Technical requirements consistent with the certificate; standard updates checked item by item (Article 19).
• □ Instructions and labels consistent with registered content (Article 39; Order No. 6, Article 4).
• □ UDI data checked (System Rules, Article 15).
• □ Post-market evidence complete: adverse event monitoring, recall and corrective action records.
• □ Grounds for refusal of renewal verified line by line against the text of Article 22, paragraph 3 (pending verification: the statutory text prevails).

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Chinese market. Our team acts as the in-China registration agent, coordinates import agent and distributor arrangements, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com